title: Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications.
abstract: Regulation of cellular responses to external stimuli such as hormones, neurotransmitters, or cytokines is achieved through the control of all steps of the complex cascade starting with synthesis, going through maturation steps, release, distribution, degradation and/or uptake of the signalling molecule interacting with the target protein. One possible way of regulation, referred to as scavenging or neutralization of the ligand, has been increasingly studied, especially for small protein ligands. It shows innovative potential in chemical biology approaches as well as in disease treatment. Neutralization of protein ligands, as for example cytokines or chemokines can lead to the validation of signalling pathways under physiological or pathophysiological conditions, and in certain cases, to the development of therapeutic molecules now used in autoimmune diseases, chronic inflammation and cancer treatment. This review explores the field of ligand neutralization and tries to determine to what extent small chemical molecules could substitute for neutralizing antibodies in therapeutic approaches.
authors.affiliation: IREBS, FRE3211, Ecole Supérieure de Biotechnologie de Strasbourg, Boulevard Sébastien Brant, 67412 Illkirch, France. galzi@unistra.fr
authors.forename: Jean-Luc
authors.initials: JL
authors.lastname: Galzi
authors.forename: Muriel
authors.initials: M
authors.lastname: Hachet-Haas
authors.forename: Dominique
authors.initials: D
authors.lastname: Bonnet
authors.forename: Francois
authors.initials: F
authors.lastname: Daubeuf
authors.forename: Sandra
authors.initials: S
authors.lastname: Lecat
authors.forename: Marcel
authors.initials: M
authors.lastname: Hibert
authors.forename: Jacques
authors.initials: J
authors.lastname: Haiech
authors.forename: Nelly
authors.initials: N
authors.lastname: Frossard
mesh_terms: D057134:Antibodies, Neutralizing / Q000627:therapeutic use*; D018925:Chemokines / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use*; D016207:Cytokines / Q000276:immunology / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy*; D008954:Models, Biological; D008958:Models, Molecular; D011485:Protein Binding; D015398:Signal Transduction / Q000276:immunology / Q000502:physiology
chemical_list: D057134:Antibodies, Neutralizing; D018925:Chemokines; D016207:Cytokines